{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:36:26Z","timestamp":1791329786796,"version":"4.3.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jdiacomp.2012.10.008","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T14:19:12Z","timestamp":1357741152000},"page":"293-300","source":"Crossref","is-referenced-by-count":47,"title":["Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes"],"prefix":"10.1016","volume":"27","author":[{"given":"Iliana","family":"Doycheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0005","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2010.18","article-title":"Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community based cohort study","volume":"105","author":"Adams","year":"2010","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0010","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity","volume":"33","author":"Adinolfi","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1665-2681(19)32036-8","volume":"5","author":"Amarapurkar","year":"2006","journal-title":"Annals of Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0020","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0030","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0035","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"issue":"Suppl S","key":"10.1016\/j.jdiacomp.2012.10.008_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1440-1746.17.s1.10.x","article-title":"Non-alcoholic fatty liver disease","volume":"17","author":"Angulo","year":"2002","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0045","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1111\/j.1572-0241.2000.02325.x","article-title":"Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease","volume":"95","author":"Bashour","year":"2000","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000282080","article-title":"Epidemiology of non-alcoholic fatty liver disease","volume":"28","author":"Bellentani","year":"2010","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0055","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archsurg.138.11.1240","article-title":"Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery","volume":"138","author":"Beymer","year":"2003","journal-title":"Archives of Surgery"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0060","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1381\/0960892055002347","article-title":"Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass","volume":"15","author":"Boza","year":"2005","journal-title":"Obesity Surgery"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0065","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0070","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0075","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/hep.21429","article-title":"Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis","volume":"44","author":"Bugianesi","year":"2006","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.jdiacomp.2012.10.008_bb0080","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0168-8278(12)60007-5","article-title":"The interaction of metabolic factors with HCV infection: does it matter?","volume":"56","author":"Bugianesi","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0085","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1464-5491.2012.03732.x","article-title":"Dorothy Hodgkin Lecture 2012* Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management","volume":"29","author":"Byrne","year":"2012","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0090","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s11745-001-0822-5","article-title":"Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients","volume":"36","author":"Cassader","year":"2001","journal-title":"Lipids"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0095","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1478-3231.2008.01956.x","article-title":"Diabetic hepatosclerosis: a 10-year autopsy series","volume":"29","author":"Chen","year":"2009","journal-title":"Liver International"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gut.2004.052167","article-title":"Diabetes increases the risk of hepatocellular carcinoma in the United States: a population-based case control study","volume":"54","author":"Davila","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2337\/diacare.22.5.756","article-title":"Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study","volume":"22","author":"de Marco","year":"1999","journal-title":"Diabetes care"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MCG.0b013e31822fb3f7","article-title":"Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?","volume":"46","author":"Domanski","year":"2012","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0125","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1572-0241.2008.02034.x","article-title":"Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study","volume":"103","author":"Dunn","year":"2008","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0135","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0140","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis","volume":"128","author":"Ertle","year":"2011","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0145","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0150","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0155","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1572-0241.2006.01041.x","article-title":"Nonalcoholic fatty liver disease in severely obese subjects","volume":"102","author":"Gholam","year":"2007","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0160","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1440-1746.2004.03312.x","article-title":"Non-alcoholic steatohepatitis in type 2 diabetes mellitus","volume":"19","author":"Gupte","year":"2004","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0165","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.5858\/132.11.1761","article-title":"Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?","volume":"132","author":"Guzman","year":"2008","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5858\/2006-130-27-DHDMOT","article-title":"Diabetic hepatosclerosis: diabetic microangioapthy of the liver","volume":"130","author":"Harrison","year":"2006","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0175","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jdiacomp.2007.11.004","article-title":"Clinical resolution of glycogenic hepatopathy fallowing improved glycemic control","volume":"22","author":"Hudacko","year":"2008","journal-title":"Journal of Diabetes and its Complications"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0180","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1309\/AJCPQBFF42ZZXXRQ","article-title":"Diabetic microangiopathy in the liver: an autopsy study of incidence and association with other diabetic complications","volume":"132","author":"Hudacko","year":"2009","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0185","doi-asserted-by":"crossref","first-page":"E906","DOI":"10.1152\/ajpendo.00117.2003","article-title":"Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance","volume":"285","author":"Kelley","year":"2003","journal-title":"American Journal of Physiology, Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1440-1746.2010.06567.x","article-title":"Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus","volume":"26","author":"Kimura","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0195","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0200","doi-asserted-by":"crossref","first-page":"d6891","DOI":"10.1136\/bmj.d6891","article-title":"Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study","volume":"343","author":"Lazo","year":"2011","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0205","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1478-3231.2011.02482.x","article-title":"Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors","volume":"31","author":"Leite","year":"2011","journal-title":"Liver International"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1381\/0960892053923888","article-title":"Hepatic histopathology of patients with morbid obesity submitted to gastric bypass","volume":"15","author":"Lima","year":"2005","journal-title":"Obesity Surgery"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0215","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0220","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver disease, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0225","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0230","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2337\/diacare.27.8.2057","article-title":"Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis","volume":"27","author":"Medina","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0235","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl. 2","key":"10.1016\/j.jdiacomp.2012.10.008_bb0240","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","article-title":"Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes","volume":"44","author":"Morrish","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0245","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl.","key":"10.1016\/j.jdiacomp.2012.10.008_bb0250","first-page":"1118A","article-title":"Clinical and histological determinants of nonalcoholic steatohepatitis (NASH) and advanced fibrosis in the elderly [abstract]","volume":"54","author":"Noureddin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0255","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1381\/0960892053576820","article-title":"Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients","volume":"15","author":"Ong","year":"2005","journal-title":"Obesity Surgery"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0260","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","article-title":"Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease","volume":"362","author":"Petersen","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/jhep.2003.50267","article-title":"Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0270","first-page":"205","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"57","author":"Prashanth","year":"2009","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2010.02.049","article-title":"Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes","volume":"56","author":"Rijzewijk","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0285","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0290","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1872-034X.2011.00824.x","article-title":"NASH: A global health problem","volume":"41","author":"Sanyal","year":"2011","journal-title":"Hepatology Research"},{"issue":"Suppl1","key":"10.1016\/j.jdiacomp.2012.10.008_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1478-3231.2010.02397.x","article-title":"Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C","volume":"31","author":"Sanyal","year":"2011","journal-title":"Liver International"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0300","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1572-0241.2003.07640.x","article-title":"Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome","volume":"98","author":"Sanyal","year":"2003","journal-title":"The American Journal of Gastroenterology"},{"issue":"Suppl 4","key":"10.1016\/j.jdiacomp.2012.10.008_bb0305","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0310","first-page":"1349","article-title":"Liver pathology in morbidly obese patients with and without diabetes","volume":"85","author":"Silverman","year":"1990","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0315","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/10408363.2011.596521","article-title":"Non-alcoholic fatty liver disease","volume":"48","author":"Smith","year":"2011","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0320","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1381\/096089203765887633","article-title":"Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass","volume":"13","author":"Spaulding","year":"2003","journal-title":"Obesity Surgery"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0325","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3748\/wjg.v16.i12.1436","article-title":"Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review","volume":"16","author":"Takuma","year":"2010","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0330","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc06-2247","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0335","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"Targher","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0340","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0345","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00000478-200604000-00012","article-title":"Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus","volume":"30","author":"Torbenson","year":"2006","journal-title":"The American Journal of Surgical Pathology"},{"issue":"Suppl 2","key":"10.1016\/j.jdiacomp.2012.10.008_bb0350","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2036.2005.02590.x","article-title":"Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study","volume":"22","author":"Trompetta","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0355","first-page":"394","article-title":"Glycogenic hepatopathy: a rare cause of elevated serum transaminases in diabetes mellitus","volume":"67","author":"van den Brand","year":"2009","journal-title":"The Netherlands Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0360","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0016-5085(88)80022-2","article-title":"Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis.Relationship to cirrhosis","volume":"95","author":"Williams","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0365","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0370","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2337\/dc10-2229","article-title":"Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study","volume":"34","author":"Williamson","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0375","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2036.2004.02012.x","article-title":"Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese","volume":"20","author":"Wong","year":"2004","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0380","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","article-title":"Nonalcoholic fatty liver disease in patients with type 2 diabetes","volume":"2","author":"Younossi","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.jdiacomp.2012.10.008_bb0385","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clinical Gastroenterology and Hepatology"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687271200298X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687271200298X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T15:30:30Z","timestamp":1644075030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687271200298X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S105687271200298X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2012.10.008","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}